Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III

ConclusionsConsent by opt-out was allowed by the protocol in this multinational trial but only a few investigators opted for it and some research ethics boards did not accept its use. It is likely to need promotion by the clinical research community to unfold its potential.
Source: Trials - Category: Research Source Type: clinical trials